Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,030 | -527 | -356 | -946 | -510 |
| Depreciation Amortization | 605 | 258 | 193 | 294 | 157 |
| Accounts receivable | -11 | -12 | -16 | -11 | -6 |
| Other Working Capital | 117 | 63 | 44 | 102 | 35 |
| Other Operating Activity | 22 | 51 | 18 | 132 | 35 |
| Operating Cash Flow | $-297 | $-166 | $-117 | $-430 | $-289 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -55 | -5 | -1 | -163 | -86 |
| Purchase Of Investment | -35 | -35 | -25 | N/A | 0 |
| Investing Cash Flow | $-90 | $-40 | $-26 | $-163 | $-86 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 276 | 204 | 45 | 719 | 578 |
| Financing Cash Flow | $276 | $204 | $45 | $719 | $578 |
| Beginning Cash Position | 128 | 128 | 128 | 1 | 1 |
| End Cash Position | 18 | 126 | 30 | 128 | 204 |
| Net Cash Flow | $-110 | $-2 | $-98 | $126 | $203 |
| Free Cash Flow | |||||
| Operating Cash Flow | -297 | -166 | -117 | -430 | -289 |
| Capital Expenditure | -55 | -5 | -1 | -163 | -86 |
| Free Cash Flow | -351 | -171 | -118 | -593 | -375 |